Skip to main content
. 2018 Oct 11;12(1):154–161. doi: 10.1016/j.tranon.2018.09.007

Figure 3.

Figure 3

According to TCGA data, patients exhibit no survival differences between TP53–wild-type and TP53-mutated tumors (n = 185 including 96 SCCs and 89 EACs).